LONG-TERM RESULTS OF ISLET ALLOGENIC TRANSPLANTATION AND PRIMARY GRAFT FUNCTION IMPACT
EFFECT OF TIME ON DIALYSIS BEFORE LIVING DONOR KIDNEY TRANSPLANTATION ON QUALITY OF LIFE AND OCCUPATIONAL REHABILITATION OF RECIPIENTS
EXOME SEQUENCING AND PREDICTION OF LONG-TERM KIDNEY ALLOGRAFT FUNCTION
ASSOCIATION BETWEEN GFR DECLINE AND LONG TERM OUTCOME IN RENAL TRANSPLANTATION
PREDICTIVE FACTORS FOR RENAL FUNCTION AFTER KIDNEY TRANSPLANTATION FROM UNCONTROLLED DONORS AFTER CIRCULATORY DEATH
KIDNEY GRAFT SURVIVAL IN ‘VALVE BLADDER’ PATIENT
IMPACT OF DONOR AGE ON OUTCOMES AFTER HEART TRANSPLANTATION IN THE MODERN ERA
SYSTEMATIC BIOPSIES OF RENAL TRANSPLANTS AT M3 IN PEDIATRICS: SECURITY AND USEFULNESS
COMPARATIVE HEALTH-RELATED QUALITY-OF-LIFE AMONG HEART TRANSPLANT VS. LONG-TERM MECHANICAL CIRCULATORY SUPPORT RECIPIENTS
TRANSPLANT PROTOCOL FROM DECEASED DONORS AFTER CIRCULATORY ARREST CATEGORIE 2 OF MAASTRICHT. RESULTS TO 8 YEARS AND RISK FACTORS FOR GRAFT FAILURE
IL-33 IS REQUIRED FOR KIDNEY ISCHEMIA-REPERFUSION-INDUCED INJURY IN MICE
HYPERCHOLESTEROLEMIA PROMOTES RENAL MICROVASCULAR REMODELING IN A PORCINE AUTO-TRANSPLANTED KIDNEY GRAFT MODEL
INFLUENCE OF COLD ISCHEMIA DURATION ON MICROVASCULAR REMODELING IN A RENAL PORCINE AUTOTRANSPLANTATION MODEL: PRELIMINARY STUDY BY MICROSCANNER
HYPOTHERMIC PULSATILE PRESERVATION OF KIDNEYS FROM UNCONTROLLED DECEASED DONORS AFTER CARDIAC ARREST
TRIMETAZIDINE IS PROTECTIVE DURING KIDNEY PRESERVATION WITH MACHINE PERFUSION
EXPLORING ISCHEMIA REPERFUSION MECHANISMS USING HIGH THROUGHPUT PROTEOMICS
ALVEOLAR AND CIRCULATING MICROPARTICLES CORRELATE WITH INFLAMMATORY ISCHEMIA REPERFUSION ACTIVATION IN A RODENT MODEL FOR EX VIVO LUNG PERFUSION
MYELOID HEME OXYGENASE-1 CONTROLS RENAL ISCHEMIA-REPERFUSION INJURY
IMPACT OF EVEROLIMUS, AN MTORC1 INHIBITOR, ON HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION: RESULTS FROM THE H2304 STUDY
OUTCOME OF RETRANSPLANTED PATIENTS AFTER POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: A FRENCH NATIONWIDE STUDY
A STRICT SELECTION OF OBESE PATIENTS MINIMIZES POST RENAL TRANSPLANT COMPLICATIONS BUT INCREASES WAITING TIME
LONG-TERM EVOLUTION LIVER TUMORIGENESIS, STEATOSIS AND FIBROSIS SCORES AFTER INTRAPORTAL ISLET TRANSPLANTATION IN TYPE 1 DIABETES
EARLY SIGNS OF ENDOCRINE PANCREAS ABNORMALITIES AND SENESCENCE IN MIDDLE AGE RATS WITH NORMAL VASCULAR FUNCTION: IMPACT FOR PANCREATIC ISLET TRANSPLANTATION
IS SYSTEMATIC CARDIOPULMONARY EXERCISE TESTING FOR PATIENTS AWAITING KIDNEY TRANSPLANTATION USEFUL?
EVEROLIMUS AND SKIN CANCER SECONDARY PREVENTION IN HEART TRANSPLANT PATIENTS. RESULTS OF THE MULTICENTER FRENCH OPEN RANDOMIZED STUDY CERTICOEUR; EVEROLIMUS VS. ANTICALCINEURINS
KIDNEY RETRANSPLANTATION IN PATIENTS HAVING PRESENTED AT LEAST ONE SQUAMOUS CELL CARCINOMA DURING A PREVIOUS TRANSPLANTATION PERIOD EXPOSES TO A HIGH RISK OF AGGRESSIVE SKIN SQUAMOUS CELL CARCINOMA
ASSOCIATION BETWEEN GUT MICROBIOTA MODIFICATIONS AND METABOLIC DISORDERS IN KIDNEY TRANSPLANTATION RECIPIENTS: THE METABIOTE-TR STUDY
EVEROLIMUS WITH REDUCED TACROLIMUS PRESERVES LONG-TERM RENAL FUNCTION IN LIVER TRANSPLANT RECIPIENTS: 36 AND 48 MONTHS RESULTS FROM THE H2304E1 STUDY
IMPACT ON RENAL FUNCTION OF STEPWISE WITHDRAWAL OF TACROLIMUS COMBINED WITH EVEROLIMUS AND ECMPS VS STANDARD TREATMENT COMBINING TACROLIMUS AND EC-MPS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: RESULTS OF THE SIMCER STUDY
BELATACEPT-TREATED PATIENTS HAD SUPERIOR GRAFT SURVIVAL COMPARED WITH CYCLOSPORINE-TREATED PATIENTS: FINAL RESULTS FROM BENEFIT
LONG-TERM SURVIVAL OUTCOMES IN BELATACEPT-TREATED VS CYCLOSPORINE-TREATED PATIENTS: FINAL RESULTS FROM BENEFIT-EXT
IMPACT OF THE CALCINEURIN INHIBITORS WITHDRAWAL FOR MYCOPHENOLATE MOFETIL MONOTHERAPY GUIDED BY THERAPEUTIC DRUG MONITORING
CONVERSION TO EVEROLIMUS (EVL) AFTER LIVER TRANSPLANTATION (LT) IN THE REAL LIFE: DATA FROM THE EVEROLIVER MULTICENTER REGISTRY
ETUDE DE LA VARIABILITÉ INTERINDIVIDUELLE DE LA RÉPONSE PHARMACOCINÉTIQUE AU TACROLIMUS PAR UN SCREENING GÉNÉTIQUE À HAUT DÉBIT
DONOR AGE, WARM ISCHEMIA TIME AND IMMUNOSUPPRESSIVE DRUGS DIFFERENTLY AFFECT ARTERIAL STIFFNESS IN RENAL TRANSPLANTATION
IMPROVED BIOAVAILABILITY AND REDUCED DOSE REQUIREMENTS OF ENVARSUS®, NOVEL ONCE-DAILY, MELTDOSE® TACROLIMUS FORMULATION COMPARED TO PROGRAF® (TAC BID, TWICE-DAILY TACROLIMUS), IN DE NOVO KIDNEY TRANSPLANTATION (KTR) PATIENTS: RESULTS OF A PHASE 3 DOUBLE-DUMMY, RANDOMIZED TRIAL
EFFICACY AND SAFETY OF SOFOSBUVIR-BASED ANTI-VIRAL THERAPY TO TREAT HEPATITIS C VIRUS INFECTION AFTER KIDNEY TRANSPLANTATION
RENAL DYSFUNCTION IN LIVER TRANSPLANT RECIPENTS TREATED WITH SOFOSBUVIR-BASED THERAPY FOR HCV RECURRENCE: RESULTS FROM THE FRENCH PROSPECTIVE MULTICENTRIC STUDY ANRS CO23 CUPILT
RISK FACTORS OF NOCARDIOSIS AFTER SOLID ORGAN TRANSPLANTATION: RESULTS FROM THE FIRST EUROPEAN RETROSPECTIVE CASE-CONTROL STUDY
KINETICS, ANTIBIORESISTANCE AND MOLECULAR EPIDEMIOLOGY OF ESCHERICHIA COLI URINARY TRACT INFECTIONS IN KIDNEY TRANSPLANT RECIPIENTS: THE PREDICOLI STUDY
RISK OF BKV VIREMIA IS NOT PREDICTABLE BEFORE KIDNEY TRANSPLANTATION WITH USUAL CLINICAL AND BIOLOGICAL DATA
FAVORABLE OUTCOME OF LATE-ONSET CMV DISEASE IN D + R-KIDNEY TRANSPLANT RECIPIENTS TREATED WITH UNIVERSAL PROPHYLAXIS
NON-INVASIVE DIAGNOSIS OF BK VIRUS-ASSOCIATED NEPHROPATHY BY USING THE URINARY PEPTIDOME
INTERLABORATORY COMPARISON OF BK VIRUS DNA LOAD MEASUREMENT: IMPACT OF VIRAL POLYMORPHISM
ARE CIRRHOTIC PATIENTS AWAITING LIVER TRANSPLANTATION PROTECTED AGAINST VACCINE PREVENTABLE DISEASES?
IS THERE A PLACE FOR THE ANALYSIS OF DSA ABILITY TO FIX C1Q AFTER KIDNEY TRANSPLANTATION IN 2015?
C3D DSA WITH HIGH MFI IS ASSOCIATED WITH A HIGHER RATE OF GRAFT LOSS IN A PEDIATRIC COHORT OF LT PATIENTS
LUMINEX SINGLE ANTIGEN ASSAYS CAN MISS CYTOTOXIC ANTIBODIES
DESCRIPTIVE ANALYSIS OF ANTI-HLA IMMUNIZATION IN A FRENCH COHORT OF LIVER TRANSPLANT CANDIDATES
INFLUENCE OF TEST TECHNIQUE ON DSA DETECTION AND ANTIBODY MEDIATED REJECTION DIAGNOSIS IN KIDNEY TRANSPLANTATION
CLASS 2 C3D-FIXING DONOR-SPECIFIC HLA ANTIBODY DETECTION IS CORRELATED TO LUMINEX MFI (MEAN FLUORESCENCE INTENSITY)
ROLE OF DONOR SPECIFIC ANTIBODIES IN PROTOCOL LIVER BIOPSIES FOLLOWING PEDIATRIC LIVER TRANSPLANTATION
IMPACT OF BLOOD TRANSFUSION AFTER KIDNEY TRANSPLANTATION ON THE INCIDENCE OF DONOR SPECIFIC ANTI-HLA ANTIBODIES
ALLOGRAFT NEPHRECTOMY IS RESPONSIBLE FOR A DELAYED SENSITIZATION AGAINST DONOR UNRELATED TO HLA ANTIBODIES GRAFT ADSORPTION
TORQUETENOVIRUS (TTV) LOAD IN BLOOD AS A MARKER OF IMMUNOSUPPRESSION IN KIDNEY TRANSPLANT RECIPIENTS
EFFECT OF HUMAN LEUCOCYTE MICROPARTICULES IN THE EPITHELIAL-MESENCHYMAL TRANSITION OF BRONCHIAL CELLS. INTEREST IN LUNG TRANSPLANTATION
TNFα: A NEW IMMUNOSUPPRESSIVE MOLECULE?
PRO-SENESCENT EFFECT OF LEUKOCYTE DERIVED-MICROPARTICLES ON ENDOTHELIAL CELLS: A NEW MECHANISM POSSIBLY CONTRIBUTING TO IBMIR IN ISLET TRANSPLANTAION
THE ENVIRONMENT INFLUENCES THE METABOLIC EFFECT OF SIROLIMUS ON HUMAN ISLETS TRANSPLANTED IN VIVO IN IMMUNODEFICIENT MICE
SHORT TERM RAPAMYCIN TREATMENT IN HEPATIC ALLOGRAFT MODEL: IMPLICATION OF IMMUNOREGULATORY CELLS IN INDUCTION OF TOLERANCE
DE NOVO PERSISTENT POST-TRANSPLANT HLA DONOR-SPECIFIC ANTIBODIES (DSA) BUT NOT PREFORMED DSA ARE ASSOCIATED WITH WORSE SURVIVAL AND AN INCREASED RISK OF CHRONIC LUNG ALLOGRAFT DYSFUNCTION (CLAD)
SUCCESSFUL TRANSPLANTATION IN ABO- AND HLA-INCOMPATIBLE KIDNEY-TRANSPLANT PATIENTS
CLINICAL OUTCOMES ASSOCIATED WITH ANTIBODY MEDIATED REJECTION IN LUNG TRANSPLANTATION
PROGNOSIS VALUE OF C1Q BINDING ANTI-HLA ANTIBODIES IN ACUTE ANTIBODY-MEDIATED REJECTION IN KIDNEY TRANSPLANTATION
TREATMENT OF ACUTE ANTIBODY-MEDIATED REJECTION IN ABO-COMPATIBLE LIVER TRANSPLANTATION
DSA CHARACTERISTICS ASSOCIATED WITH ANTIBODY MEDIATED REJECTION IN LUNG TRANSPLANTATION
PERIOPERATIVE AND EARLY POSTOPERATIVE COMPLICATIONS AFTER LIVER TRANSPLANTATIONS (LT) FROM TYPE 2-DONATION AFTER CARDIAC DEATH IN FRANCE (TYPE2-DCD): A CASE-CONTROL STUDY
PREOPERATIVE RISK FACTORS FOR INTRA-OPERATIVE BLEEDING IN PEDIATRIC LIVER TRANSPLANTATION
FIRST PURE ROBOTIC-ASSISTED SEQUENCE LIVING DONOR «NEPHRECTOMY - KIDNEY TRANSPLANTATION» WITH TRANSVAGINAL EXTRACTION AND INTRODUCTION OF THE GRAFT
BILIARY COMPLICATIONS AFTER “EN BLOC” LIVER BOWEL OR MULTIVISCERAL TRANSPLANTATION IN CHILDREN
EARLY AND MIDTERM RESULTS OF INFRARENAL AORTIC ALLOGRAFTS USED IN VASCULAR INFECTIONS
EARLY POSTTRANSPLANT COMPLICATIONS FOLLOWING ABO-INCOMPATIBLE KIDNEY TRANSPLANTATION
TIME-VARYING EFFECT OF PREEMPTIVE SECOND KIDNEY TRANSPLANTATION ON GRAFT SURVIVAL
LONG TERM EFFECT OF THE HEART DONOR SCORE ON PATIENT SURVIVAL
PREEMPTIVE TRANSPLANTATION IS ASSOCIATED WITH IMPROVED GRAFT SURVIVAL: RESULTS FROM THE FRENCH TRANSPLANT DATABASE
EARLY URINARY CXCL10 IS PREDICTIVE OF SUBSEQUENT ACUTE REJECTION IN CLINICALLY AND HISTOLOGICALLY STABLE KIDNEY RECIPIENTS
ADCC OF NK CELLS IN KIDNEY TRANSPLANTATION: A NEW COMPLEMENT-INDEPENDENT TOOL OF DSA MONITORING
EPITOPE LOAD IS PREDECTIVE OF DE NOVO CLASS II DSA OCCURRENCE IN RENAL TRANSPLANT RECIPIENTS AFTER CONVERSION FROM CYCLOSPORINE TO EVEROLIMUS
EFFICACY AND SAFETY STUDY AFTER A 4-MONTH POST-RENAL TRANSPLANT DOSE REDUCTION OF TACROLIMUS (ADEQUATE STUDY)
EARLY INTRODUCTION OF SUBCUTANEOUS (S.C.) HEPATITIS B IMMUNOGLOBULIN (HBIG) PROVIDES EFFECTIVE PROPHYLAXIS FOR HEPATITIS B VIRUS (HBV) REINFECTION AFTER LIVER TRANSPLANTATION (TX)
B CELLS LOADED WITH SYNTHETIC PARTICULATE ANTIGENS: AN ALTERNATIVE PLATFORM TO GENERATE ANTIGEN-SPECIFIC REGULATORY T CELLS FOR ADOPTIVE CELL THERAPY